We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cancer Therapies Derived from Marine Animals

By Biotechdaily staff writers
Posted on 05 Aug 2008
Scientists from Aberdeen, Luxembourg, and the South Pacific have studied the properties of natural products derived from animals found in Fijian waters, and demonstrated that not only many specific compounds found in these organisms have potential use in anticancer therapies, but others may also be useful for improving drug delivery, currently one of the most significant problems faced by medical researchers. More...


Prof. Marcel Jaspars, from the University of Aberdeen (UK), presented insights into these new compounds on July 7, 2008, at the Society for Experimental Biology's annual meeting in Marseille, France.

The investigators focused on finding compounds that interfere with a protein called nuclear factor-kappa B (NF-kB). This specific protein is known to have a crucial role in many types of cancer, as well as a number of other diseases including inflammatory bowel disease, arthritis, and asthma, so there is a major drive to find molecules which can inhibit its activity. "We have tested a large number of marine species to see which can prevent NF-kB from working,” explains Prof. Jaspars. "A few animals, including sponges, soft corals, and sea lilies, were examined further, and from these we have been able to isolate and characterize the compounds responsible. We have shown that one of these molecules is able to allow normal cell death [which NK-kB switches off in some cancerous cells] to start up again, a property which we will be going onto study in much more detail.”

There is another possible application of molecules isolated from marine creatures that has the potential to have just as great an impact on the development of new medicines. "It is an unfortunate reality that currently, many new excellent drugs are discovered that cannot be delivered effectively to the places where they are required,” Prof. Jaspars revealed. "However, we have isolated one compound from a Mediterranean sponge that may help to end this trend. This molecule can reversibly create pores in cell membranes, a property for we envisage vast possibilities in the transportation of medicinal drugs. As we can now make this compound in the lab in large quantities, we are now able to investigate possible applications of the molecule, including drug delivery into tumors, gene delivery for cystic fibrosis and delivery of drugs into the eye.”

NF-kB is a protein complex found to regulate gene expression. It is involved in immune responses to infection and has been demonstrated to play a role in many diseases including cancer, inflammatory and autoimmune diseases.


Related Links:
University of Aberdeen

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Immunofluorescence Analyzer
IFA System
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.